Edition:
United States

Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

3.88USD
24 Mar 2017
Change (% chg)

$-0.04 (-1.02%)
Prev Close
$3.92
Open
$3.94
Day's High
$3.97
Day's Low
$3.87
Volume
737,356
Avg. Vol
1,204,068
52-wk High
$7.49
52-wk Low
$2.97

Select another date:

Tue, Feb 14 2017

BRIEF-Incyte and Agenus amend collaboration agreement

* Incyte Corp - amended agreement converts ongoing GITR and ox40 antibody programs from co-funded development and profit-sharing arrangements to royalty-bearing programs

BRIEF-Venbio Select Advisor LLC reports a 5.41 pct passive stake in Agenus

* Venbio Select Advisor Llc reports a 5.41 passive stake in Agenus Inc as on December 31, 2016 - sec filing Source text - http://bit.ly/2lpg9SS Further company coverage:

BRIEF-QVT Financial reports 5.08 pct passive stake in Agenus

* QVT Financial Lp reports a 5.08 percent passive stake in Agenus Inc as of January 24, 2017 - sec filing Source text - http://bit.ly/2jHW6OQ Further company coverage:

BRIEF-Agenus files for offering of up to 157,513 shares by selling stockholder

* Files for offering of up to 157,513 shares of co's common stock by the selling stockholder - SEC filing Source text: (http://bit.ly/2jIMpis) Further company coverage:

BRIEF-Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine

* Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine

BRIEF-Agenus reports Q3 loss per share $0.47

* Agenus reports third quarter financial results and recent highlights

Select another date:

More From Around the Web